Chemotherapy Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025– Increasing prevalence of various types of cancers among population is a key factor driving the growth of Global Chemotherapy Treatment Market.
Chemotherapy Treatment Market is valued at USD 11053.0 Million in 2018 and expected to reach USD 19565.5 Million by 2025 with the CAGR of 8.5% over the forecast period
Chemotherapy is a type of cancer treatment which involves the application of cancer destroying drugs. In more explanation, chemotherapy drugs interfere with a cell’s ability to divide and reproduce i.e. it destroy the reoccurring cancerous cell. In this treatment a single drug or a combination of drugs is used. That drug can be delivered either directly into the bloodstream, to attack cancer cells throughout the body, or they can be targeted to specific cancer sites. Generally, chemotherapy is the use of any drug to treat any type of disease. But mostly people supposed that, the word chemotherapy means drugs used for cancer treatment. Surgery and radiation therapy remove, kill, or damage cancer cells in a certain area, but chemo can work throughout the body. This means chemo can kill cancerous cells that have spread (metastasized) to that parts of the body which are far away from the original tumor. Cancer has a widespread prevalence all over the world and chemotherapy is a most widely used treatment for various types of cancer found to be prevalent across the globe which increases the demand for cancer drugs.
Global Chemotherapy Treatment Market report is segmented on the basis of drug class, indication, rout of administration, end-user and region & country level. Based upon drug class, chemotherapy Treatment market is classified into alkylating agents, mitotic inhibitors, antimetabolites, topoisomerase inhibitors, antitumor antibiotic and others. On the basis of indication, market is classified into lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, lymphoma, leukemia, ovarian cancer and others. On the basis of rout of administration, market is classified into intravenous, oral, subcutaneous, intra-muscular, intravehicular, topical, intraperitoneal, intraventricular/intrathecal and others. On the basis of end-user, market is classified into specialty center, hospitals & clinics and others.
North America is Expected to Dominate the Global Chemotherapy Treatment Market.
By region, the global chemotherapy treatment market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America is currently the leading contributing region to the global chemotherapy treatment market owing to the presence of large numbers of research and production hubs of several conglomerate pharmaceuticals and contract research organizations and extensive investments by them in this region. Europe is projected to witness considerable growth owing to the availability of funds and government support for research & development. However, the Asia Pacific region is expected to register the highest CAGR during the forecast period 2018-2025 due to rising patient pool and increasing healthcare expenditure.